We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Test Detects Premature Rupture of Fetal Membrane

By HospiMedica staff writers
Posted on 29 Oct 2003
A new test detects the premature rupture of fetal membrane (PROM), which occurs in around 10% of pregnant women, influencing pre- and postnatal morbidity and mortality.

PROM occurs when a pregnant woman's amniotic fluid sac breaks prematurely and is not followed by labor in 24-48 hours. More...
About 30% of pregnant women are checked for PROM. If the rupture of the amniotic sac, which causes leakage of amniotic fluid, is not detected and treated in a timely manner, serious complications for the neonate and the mother may occur.

The test, called AmniSure, detects premature fetal membrane rupture. No reliable diagnostic for PROM exists today, states N-Dia, Inc. (Boston, MA, USA), which developed the test. The company believes that current tests (nitrazine test or ferning, for example) date from the 1950s and are both inaccurate and invasive (requiring a mandatory speculum examination). In contrast, AmniSure is a rapid noninvasive strip test that provides an answer in a few minutes, whether used in a clinic or at home.

N-Dia is a medical device company developing diagnostic products based on its research in cellular biology. These products utilize proprietary monoclonal antibodies against specific proteins associated with particular disorders and diseases. The company has developed a method that allows a diagnostic device to detect very small quantities of these proteins. The company states that this permits early and accurate detection of a dangerous medical condition and provides the possibility of timely treatment.




Related Links:
N-Dia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Monitoring System
AlarmSense
New
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.